Picard Medical wins NYSE American approval of plan to regain listing compliance - PMI News | RalliesPicard Medical wins NYSE American approval of plan to regain listing compliance
P
PMI• NYSE American approves compliance plan
- NYSE American accepted Picard Medical’s plan to regain compliance with continued listing standards under Sections 1003(a)(i) and (ii).
- The decision keeps the stock listed on NYSE American under PMI while the company executes its remediation plan.
- The compliance window runs through Nov. 8, 2027, subject to periodic exchange review and ongoing adherence to other listing standards.
